in3logo An integrated interdisciplinary approach to animal-free nanomaterial and chemical safety assessment.

::home::      ::progress::      ::partners::      ::training::      ::about in3::      .:ESTIV home:.     
The in3 project is funded by the EU's Marie Sklodowska-Curie Action - Innovative Training Network (MSCA-ITN for short) that aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial (NM) safety assessment. Here are our dedicated, motivated, dynamic, early stage researchers.







Coordinator: Paul Jennings p.jennings@vu.nl
Training coordinator: Maxime Culot  maxime.culot@univ-artois.fr
Project manager: Dr. Ellen Langemeijer e.v.langemeijer@vu.nl



                 




  in3 session ESTIV 2018 Berlin



The picture after our  in3 session flash presentation bonanza at the 20th International Congress on In Vitro Toxicology (ESTIV2018) New approach methodologies for in vitro toxicology applications at the Estrel Hotel Berlin Sonnenallee 225, Berlin, Germany, October 2018.  


in3 session Project Meetings and Training




Toxicity Assay hands on training. November 2018, Molecular and Computational Toxicity VU Amsterdam.




ESRs, PIs and SAB April 2018, The Last Supper, Milan. 




Building AOPs and the use of the AOP wiki / OECD Toolbox, hands on training July 2018, Liverpool John Moores University, Liverpool, United Kindgom. 





in3 kick off meeting. ESRs, PIs and SAB October 2017, O2 building  VU, Amsterdam.



  Publications

  1. Rauch, C., Feifel, E., Kern, G., Murphy, C., Meier, F., Parson, W., Beilmann, M., Jennings, P., Gstraunthaler, G., Wilmes, A., 2018. Differentiation of human iPSCs into functional podocytes. PLoS One 13, e0203869. doi:10.1371/journal.pone.0203869/a>

 
 

in3 is funded by the Marie Sklodowska-Curie Action - Innovative Training Network under grant no. 721975.